Biopharmaceutical Manufacturing Market Trends, Demand, Regional Analysis and Forecast 2024

1. Global Biopharmaceutical Manufacturing Market Research Report and Forecast 2024 Report Edition: 2019 Copyright © IMARC Service Pvt Ltd. All Rights Reserved © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Biopharmaceutical Manufacturing Market Overview: According to the latest report by IMARC Group, titled “Biopharmaceutical Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global biopharmaceutical manufacturing market size Biopharmaceutical manufacturing is a highly complex research and development process involving considerable investments in terms of capital and time to build specialized manufacturing facilities and equipment. An increase in the demand for biosimilars, which are useful in the treatment of various chronic diseases, has led to the introduction of new and improved manufacturing techniques. They have helped in reducing costs, increasing efficiencies and improving weak development pipelines, especially in the developing regions. reached US$ 5.4 Million Liters in 2018. Global Biopharmaceutical Manufacturing Market Trends Nowadays, the vast majority of the global population suffers from acute diseases, resulting in the rising demand for biopharmaceutical drugs. Besides this, significant advancements have been made in the fields of medical science and engineering over the past few decades, which have enabled the implementation of continuous pharmaceutical manufacturing.

4. Report Description and Highlights Report Description 186.5 181.2 120.2125.5130.8136.1141.4146.7152.0157.3 175.9 170.6 160 180 165.3 160.0 160 140 140 120 In Million US$ in Million US$ 120 100 100 80 80 60 60 40 40 20 20 0 0 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 This has prompted the leading companies to produce these medicines on a larger scale. Moreover, several companies are outsourcing various production activities to contract manufacturers due to the significant cost savings, innovation and specific capabilities offered by them. Looking forward, the market is projected to witness moderate growth during 2019-2024. Request for a free sample report: https://www.imarcgroup.com/global-biopharmaceutical- manufacturing-market/requestsample

5. Report Description and Highlights Report Description The increasing healthcare spending has further led to the development of international biomanufacturing centers that focus on single-use technology. This helps in improving operational costs by increasing process flexibility and offering higher product yield. Additionally, the use of this technology helps in creating a greener manufacturing platform as it tends to consume fewer raw materials, water and utilities and has a smaller carbon footprint than traditional processing. Key Market Segmentation: Market Segmentation by Class • • • • • • • • Monoclonal Antibodies Recombinant Proteins Interferon Granulocyte Colony-Stimulating Factor (G-CSF) Erythropoietin Recombinant Human Insulin Vaccines Human Growth Hormones (HGH)

6. Report Description and Highlights Report Description Based on class, the report finds that recombinant proteins dominate the market. Other major class segments are monoclonal antibodies, interferons, erythropoietin, granulocyte colony-stimulating factor (G-CSF), recombinant human insulin, vaccines and human growth hormones (HGH). For more information, click here: https://www.imarcgroup.com/global-biopharmaceutical- manufacturing-market Market Segmentation by Region • • • • • • • • • • United States Canada United Kingdom Germany France Italy Spain Russia Brazil Australia

7. Report Description and Highlights Report Description Region-wise, North America currently represents the largest market, accounting for nearly half of the total market share. Other major regions include Europe and Asia Pacific. Market Segmentation by Cell Culture • • Mammalian Cell Culture Microbial Cell Culture On the basis of cell culture, the market has been segmented into mammalian and microbial cell cultures. Amongst these, mammalian cell culture represents the largest category, holding the majority of the production volume. Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players. • • Roche Amgen

8. Report Description and Highlights Report Description • • • • • • • • Novo Nordisk AbbVie Sanofi S.A Johnson & Johnson Pfizer Merck & Co. Lilly Biogen Idec Browse Related Report HIV Drugs Market Report: https://www.imarcgroup.com/hiv-drug-market Hormone Replacement Therapy Market Report: https://www.imarcgroup.com/hormone- replacement-therapy-market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com